189 related articles for article (PubMed ID: 30451112)
1. Overexpression of Nemo-like Kinase Promotes the Proliferation and Invasion of Lung Cancer Cells and Indicates Poor Prognosis.
Lei L; Wang Y; Zheng YW; Fei LR; Shen HY; Li ZH; Huang WJ; Yu JH; Xu HT
Curr Cancer Drug Targets; 2019; 19(8):674-680. PubMed ID: 30451112
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Nemo‑like kinase promotes metastasis in non‑small‑cell lung cancer.
Shi C; Xu L; Tang Z; Zhang W; Wei Y; Ni J; Zhang S; Feng J
Oncol Rep; 2019 Sep; 42(3):1090-1100. PubMed ID: 31322229
[TBL] [Abstract][Full Text] [Related]
3. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
[TBL] [Abstract][Full Text] [Related]
4. TRIP13 promotes the proliferation and invasion of lung cancer cells via the Wnt signaling pathway and epithelial-mesenchymal transition.
Li ZH; Lei L; Fei LR; Huang WJ; Zheng YW; Yang MQ; Wang Z; Liu CC; Xu HT
J Mol Histol; 2021 Feb; 52(1):11-20. PubMed ID: 33128167
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
[TBL] [Abstract][Full Text] [Related]
6. DEK promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas.
Yang MQ; Bai LL; Lei L; Zheng YW; Wang Z; Li ZH; Liu CC; Huang WJ; Xu HT
Oncol Rep; 2020 Apr; 43(4):1338-1348. PubMed ID: 32020224
[TBL] [Abstract][Full Text] [Related]
7. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.
Wang K; Wang X; Zou J; Zhang A; Wan Y; Pu P; Song Z; Qian C; Chen Y; Yang S; Wang Y
Neuro Oncol; 2013 May; 15(5):578-88. PubMed ID: 23416699
[TBL] [Abstract][Full Text] [Related]
8. Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling Pathway.
Che J; Yue D; Zhang B; Zhang H; Huo Y; Gao L; Zhen H; Yang Y; Cao B
Int J Med Sci; 2018; 15(4):339-351. PubMed ID: 29511369
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
[TBL] [Abstract][Full Text] [Related]
10. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
[TBL] [Abstract][Full Text] [Related]
11. Expression of Nemo-like kinase was increased and negatively correlated with the expression of TCF4 in lung cancers.
Zhang XW; Chen SY; Xue DW; Xu HH; Yang LH; Xu HT; Wang EH
Int J Clin Exp Pathol; 2015; 8(11):15086-92. PubMed ID: 26823848
[TBL] [Abstract][Full Text] [Related]
12. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of Nemo-like kinase (NLK) in the regulation of cancers.
Huang Y; Yang Y; He Y; Li J
Tumour Biol; 2015 Dec; 36(12):9147-52. PubMed ID: 26427665
[TBL] [Abstract][Full Text] [Related]
14. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
[TBL] [Abstract][Full Text] [Related]
15. Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and β-catenin.
Wang Y; Lei L; Zheng YW; Zhang L; Li ZH; Shen HY; Jiang GY; Zhang XP; Wang EH; Xu HT
Cancer Sci; 2018 Jun; 109(6):1799-1810. PubMed ID: 29660200
[TBL] [Abstract][Full Text] [Related]
16. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
[TBL] [Abstract][Full Text] [Related]
17. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
18. FAM83A Promotes Lung Cancer Progression by Regulating the Wnt and Hippo Signaling Pathways and Indicates Poor Prognosis.
Zheng YW; Li ZH; Lei L; Liu CC; Wang Z; Fei LR; Yang MQ; Huang WJ; Xu HT
Front Oncol; 2020; 10():180. PubMed ID: 32195172
[TBL] [Abstract][Full Text] [Related]
19. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
[TBL] [Abstract][Full Text] [Related]
20. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
Yang S; Liu Y; Li MY; Ng CSH; Yang SL; Wang S; Zou C; Dong Y; Du J; Long X; Liu LZ; Wan IYP; Mok T; Underwood MJ; Chen GG
Mol Cancer; 2017 Jul; 16(1):124. PubMed ID: 28716029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
